coronary atherosclerotic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meets the Western diagnostic criteria for unstable angina pectoris in coronary heart disease, with a severity of grade I-III angina pectoris; (2) Meets the traditional Chinese medicine diagnostic criteria for qi and yin deficiency syndrome in chest obstruction and heart pain disease; (3) Age >= 18 years old; (4) Voluntarily participate and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Traditional Chinese patent medicines and simple preparations or decoction pieces of traditional Chinese medicine that have similar effects to those of supplementing qi and restoring pulse for injection (freeze-drying); (2) Those who have a treatment course of less than 7 days and are unable to complete subsequent treatment or follow-up procedures; (3) Participants in other clinical trials; (4) The researcher determines that they cannot complete or are not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite endpoint incidence of major adverse cardiovascular events (MACE);Detect the structure, function, and diversity of gut microbiota in the sample.;Changes in gut microbiota structure in patients with unstable angina pectoris and coronary heart disease before and after intervention with injection of Yiqi Fumai (freeze-drying).; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Symptom Grading Score;CCS Class;seattle angina questionnaire;European Five Dimensional Health Scale;Electrocardiogram efficacy;Cardiac function assessment;Angina pectoris efficacy score; | — |
Countries
China
Contacts
The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine